J1030 – Injection, methylprednisolone acetate, 40 mg
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ1030
- Long description
- Injection, methylprednisolone acetate, 40 mg
- Short description
- Methylprednisolone 40 mg inj
- Pricing indicator
51Drugs- Medicare coverage
DSpecial coverage instructions apply- BETOS category
O1EOther drugs- Added
- January 1, 1982
- Last change
- April 1, 2024 – No change
- Termination date
- March 31, 2024
Frequently asked questions
What is HCPCS code J1030?
J1030 is a HCPCS Level II code for injection, methylprednisolone acetate, 40 mg. It was discontinued on March 31, 2024.
Does Medicare cover J1030?
The HCPCS file lists coverage code D: Special coverage instructions apply. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J0899 – Injection, argatroban (auromedics), not therapeutically equivalent to j0884, 1 mg (for esrd on dialysis)
- J0900 – Injection, testosterone enanthate and estradiol valerate, up to 1 cc
- J0901 – Vadadustat, oral, 1 mg (for esrd on dialysis)
- J0911 – Instillation, taurolidine 1.35 mg and heparin sodium 100 units (central venous catheter lock for adult patients receiving chronic hemodialysis)
- J0945 – Injection, brompheniramine maleate, per 10 mg
- J1000 – Injection, depo-estradiol cypionate, up to 5 mg
- J1010 – Injection, methylprednisolone acetate, 1 mg
- J1020 – Injection, methylprednisolone acetate, 20 mg
- J1040 – Injection, methylprednisolone acetate, 80 mg
- J1050 – Injection, medroxyprogesterone acetate, 1 mg
- J1060 – Injection, testosterone cypionate and estradiol cypionate, up to 1 ml
- J1070 – Injection, testosterone cypionate, up to 100 mg
- J1071 – Injection, testosterone cypionate, 1 mg
- J1072 – Injection, testosterone cypionate (azmiro), 1 mg
- J1073 – Testosterone pellet, implant, 75 mg
- J1080 – Injection, testosterone cypionate, 1 cc, 200 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.